246 related articles for article (PubMed ID: 23179277)
1. Preparation of hyaluronic acid micro-hydrogel by biotin-avidin-specific bonding for doxorubicin-targeted delivery.
Cui Y; Li Y; Duan Q; Kakuchi T
Appl Biochem Biotechnol; 2013 Jan; 169(1):239-49. PubMed ID: 23179277
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid-modified multiwalled carbon nanotubes for targeted delivery of doxorubicin into cancer cells.
Cao X; Tao L; Wen S; Hou W; Shi X
Carbohydr Res; 2015 Mar; 405():70-7. PubMed ID: 25500334
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronate tethered, "smart" multiwalled carbon nanotubes for tumor-targeted delivery of doxorubicin.
Datir SR; Das M; Singh RP; Jain S
Bioconjug Chem; 2012 Nov; 23(11):2201-13. PubMed ID: 23039830
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery.
Song E; Han W; Li C; Cheng D; Li L; Liu L; Zhu G; Song Y; Tan W
ACS Appl Mater Interfaces; 2014 Aug; 6(15):11882-90. PubMed ID: 25000539
[TBL] [Abstract][Full Text] [Related]
5. Injectable and thermoresponsive self-assembled nanocomposite hydrogel for long-term anticancer drug delivery.
Chen YY; Wu HC; Sun JS; Dong GC; Wang TW
Langmuir; 2013 Mar; 29(11):3721-9. PubMed ID: 23441993
[TBL] [Abstract][Full Text] [Related]
6. Interconnected hyaluronic acid derivative-based nanoparticles for anticancer drug delivery.
Park JH; Cho HJ; Termsarasab U; Lee JY; Ko SH; Shim JS; Yoon IS; Kim DD
Colloids Surf B Biointerfaces; 2014 Sep; 121():380-7. PubMed ID: 24993066
[TBL] [Abstract][Full Text] [Related]
7. Sustained release formulation of erythropoietin using hyaluronic acid hydrogels crosslinked by Michael addition.
Hahn SK; Oh EJ; Miyamoto H; Shimobouji T
Int J Pharm; 2006 Sep; 322(1-2):44-51. PubMed ID: 16781096
[TBL] [Abstract][Full Text] [Related]
8. Conjugating an anticancer drug onto thiolated hyaluronic acid by acid liable hydrazone linkage for its gelation and dual stimuli-response release.
Fu C; Li H; Li N; Miao X; Xie M; Du W; Zhang LM
Carbohydr Polym; 2015 Sep; 128():163-70. PubMed ID: 26005152
[TBL] [Abstract][Full Text] [Related]
9. Preparation of thermoresponsive and pH-sensitivity polymer magnetic hydrogel nanospheres as anticancer drug carriers.
Fan T; Li M; Wu X; Li M; Wu Y
Colloids Surf B Biointerfaces; 2011 Dec; 88(2):593-600. PubMed ID: 21871786
[TBL] [Abstract][Full Text] [Related]
10. Selectively crosslinked hyaluronic acid hydrogels for sustained release formulation of erythropoietin.
Motokawa K; Hahn SK; Nakamura T; Miyamoto H; Shimoboji T
J Biomed Mater Res A; 2006 Sep; 78(3):459-65. PubMed ID: 16721757
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin.
Yadav AK; Mishra P; Jain S; Mishra P; Mishra AK; Agrawal GP
J Drug Target; 2008 Jul; 16(6):464-78. PubMed ID: 18604659
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid thiol modified injectable hydrogel: Synthesis, characterization, drug release, cellular drug uptake and anticancer activity.
Xu K; Yao H; Fan D; Zhou L; Wei S
Carbohydr Polym; 2021 Feb; 254():117286. PubMed ID: 33357859
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and degradation test of hyaluronic acid hydrogels.
Hahn SK; Park JK; Tomimatsu T; Shimoboji T
Int J Biol Macromol; 2007 Mar; 40(4):374-80. PubMed ID: 17101173
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
15. An injectable hyaluronic acid-tyramine hydrogel system for protein delivery.
Lee F; Chung JE; Kurisawa M
J Control Release; 2009 Mar; 134(3):186-93. PubMed ID: 19121348
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of biotin-conjugated pH-responsive polymeric micelles as drug carriers.
Kim JH; Li Y; Kim MS; Kang SW; Jeong JH; Lee DS
Int J Pharm; 2012 May; 427(2):435-42. PubMed ID: 22342467
[TBL] [Abstract][Full Text] [Related]
17. In situ formation of chitosan-gold hybrid hydrogel and its application for drug delivery.
Chen R; Chen Q; Huo D; Ding Y; Hu Y; Jiang X
Colloids Surf B Biointerfaces; 2012 Sep; 97():132-7. PubMed ID: 22609593
[TBL] [Abstract][Full Text] [Related]
18. Effect of cross-linking reagents for hyaluronic acid hydrogel dermal fillers on tissue augmentation and regeneration.
Yeom J; Bhang SH; Kim BS; Seo MS; Hwang EJ; Cho IH; Park JK; Hahn SK
Bioconjug Chem; 2010 Feb; 21(2):240-7. PubMed ID: 20078098
[TBL] [Abstract][Full Text] [Related]
19. Crosslinked hyaluronic acid hydrogels: a strategy to functionalize and pattern.
Segura T; Anderson BC; Chung PH; Webber RE; Shull KR; Shea LD
Biomaterials; 2005 Feb; 26(4):359-71. PubMed ID: 15275810
[TBL] [Abstract][Full Text] [Related]
20. Effects of cross-linking molecular weights in a hyaluronic acid-poly(ethylene oxide) hydrogel network on its properties.
Noh I; Kim GW; Choi YJ; Kim MS; Park Y; Lee KB; Kim IS; Hwang SJ; Tae G
Biomed Mater; 2006 Sep; 1(3):116-23. PubMed ID: 18458391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
